Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Journal of Clinical Pharmacology|June 12, 2025
Pharmacogenetic Approaches to Optimize Bioequivalence Studies in Generic Drug DevelopmentJihyun Bae, Jihong Shon, Myong-Jin Kim, et al.Clinical Pharmacology and Therapeutics|November 11, 2018
Generating Model Integrated Evidence for Generic Drug Development and AssessmentLiang Zhao, Myong-Jin Kim, Lei Zhang, et al.Journal of Clinical Pharmacology|September 20, 2017
Model-Based Assessment Using Conventional Bioequivalence Limits to Ensure Safety and Efficacy of Rivaroxaban in Patients Undergoing Hip or Knee ReplacementMario González-Sales, Lanyan Fang, Myong-Jin Kim, et al.Current Neurology and Neuroscience Reports|September 21, 2017
Risk-Based Bioequivalence Recommendations for Antiepileptic DrugsZhichuan Li, Lanyan Fang, Wenlei Jiang, et al.Ultrasonics|February 16, 2015
Study on the vibration displacement distribution of a circular ultrasonic motor statorChol-Su Ri, Myong-Jin Kim, Chol-Su Kim, et al.Journal of Clinical Pharmacology|February 24, 2006
Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adultsYanhua Zhang, Myong-Jin Kim, Joseph S Bertino, et al.Journal of Clinical Pharmacology|January 31, 2009
A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunityMyong-Jin Kim, Shiew-Mei Huang, Urs A Meyer, et al.International Journal of Pharmaceutics|May 18, 2024
Designs of clinical swallowability assessments of solid oral dosage forms in regulatory submissionsMeredith R McGuire, Agm Mostofa, Jihong Shon, et al.Journal of Clinical Pharmacology|June 17, 2004
Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosingMyong-Jin Kim, Joseph S Bertino, Tara A Erb, et al.Clinical Pharmacology and Therapeutics|August 22, 2002
Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarkerMyong-Jin Kim, Joseph S Bertino, Andrea Gaedigk, et al.Pageof 5